malaysia onclogy
   
 
malaysiaoncology.org | Malaysian Oncological Society
home home home home
    search
Terminology
Misconceptions
Diagnosis
Treatments
Common Cancers
Informed Decision
Featured Expert
Palliative Care
Specialist Centres
Upcoming Events
Frequently Asked Questions
Web Resources
In the News & Newsletters
Supportive Info
Clinical Trials
Photo Gallery
Cancer Survivorship
President's Message
Living with Cancer
Toolbox
Join as a Member of MOS
MOS Committee
Announcements & Updates
Home
Feedback
   
 

Main sponsors:
AstraZeneca Sdn Bhd
Novartis Corporation (Malaysia) Sdn. Bhd
Roche (Malaysia) Sdn. Bhd.
Sanofi-Aventis Malaysia Sdn Bhd
GlaxoSmithKline Pharmaceutical Sdn Bhd
Pfizer Malaysia Sdn Bhd
  arrow Clinical Trials

 

Non-Small Cell Lung Cancer (NSCLC) - Multinational Clinical Research Study

20 July 2006


You’re invited

We are looking for patients to participate in a multinational clinical research study evaluating a novel investigational medication for non-small cell lung cancer.

To be eligible for screening, you must be 18 years old or greater, with NSCLC of stage IIIB or IV and be able to take oral medication.

During your participation, you will be closely monitored by our research team with regular clinical visits, blood tests and imaging scans.

To find out more … Call now!!

Ms Julaiha Beevee

Tel No: 03 – 7949 2120 or 016 – 373 2649

Time: Monday – Friday 9.00 a.m. to 5.00 p.m.
 


  printer Printer-friendly version


  back   Go Back




HOPE handbook A Resource Guidebook for Newly Diagnosed Cancer Patients
» HOPE Handbook
 

HOPE handbook 2 A Guide for Cancer Caregivers
» HOPE Handbook 2
 
terms of use | sponsors | credits

Copyright © malaysiaoncology.org 2004 - 2012   All rights reserved
designed & maintained: mobition